• Molecular NameDexmedetomidine
  • SynonymMedetomidina [Spanish]; Medetomidine; Medetomidinum [Latin]
  • Weight200.285
  • Drugbank_IDDB00633
  • ACS_NO113775-47-6
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)2.97
  • pkaN/A
  • LogD (pH=7, predicted)2.53
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.84
  • LogSw (predicted, AB/LogsW2.0)0.09
  • Sw (mg/ml) (predicted, ACD/Labs)0.15
  • No.of HBond Donors1
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds2
  • TPSA28.68
  • StatusFDA approved
  • AdministrationIntravenous infusion only
  • PharmacologyA sedative medication used by intensive care units and anesthesiologists,
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding94.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmNear complete hepatic metabolism to inactive metabolites
  • Half life2 h
  • Excretionurinary
  • Urinary ExcretionN/A
  • Clerance0.80 L/min
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A